Nascent Pharma Holdings, Inc.

Nascent Pharma Holdings, Inc.

NASC
Nascent Pharma Holdings, Inc.US flagOther OTC
0.01
USD
- -
- -
985,946.00Market Cap

Nascent Pharma Holdings, Inc. (NASC) Stock Split History

Learn about Nascent Pharma Holdings, Inc.'s most recent 1-for-15 basis stock split on February 14, 2022. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Nascent Pharma Holdings, Inc.'s most recent stock split

Split Date: 2022-02-14
Split Ratio: 1:15
Price Before Split: $0.04
Price After Split: $0.00

Developer API

Get NASC split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/NASC

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Nascent Pharma Holdings, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-02-141:15Yes$0.04$0.00
2020-03-061:300Yes$0.00$0.00
2013-06-041:10Yes$0.00$0.00

About Nascent Pharma Holdings, Inc.

Company overview and industry information

Nascent Pharma Holdings, Inc. (NASC) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Drug Manufacturers - Specialty & Generic
Go to Nascent Pharma Holdings, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.